The FDA approval of aducanumab has given hope to millions of patients with Alzheimer disease—but will it live up to the hype?
George Perry, PhD
Advertisement
Dr Perry is the Semmes Foundation Distinguished University Chair in Neurobiology at the University of Texas, San Antonio.
Articles by George Perry, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
